CABOTEGRAVIR

Clinical trials for CABOTEGRAVIR explained in plain language.

Never miss a new study

Get alerted when new CABOTEGRAVIR trials appear

Sign up with your email to follow new studies for CABOTEGRAVIR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New injectable HIV combo trial pulled before it began

Disease control Terminated

This was a planned phase 2 study to test a combination of two long-acting drugs, cabotegravir and lenacapavir, for people with HIV who have tried many treatments. The goal was to see if switching to these injections every two months could keep the virus under control. However, th…

Matched conditions: CABOTEGRAVIR

Phase: PHASE2 • Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC

CABOTEGRAVIR

Get alerted when new CABOTEGRAVIR trials appear

New injectable HIV combo trial pulled before it began